The Multiple Sclerosis Centre of the Veneto Region, First Neurology Clinic, Department of Neurosciences, University Hospital of Padova, Italy.
Mult Scler. 2013 Jun;19(7):904-11. doi: 10.1177/1352458512463767. Epub 2012 Oct 15.
Although a more favorable course of multiple sclerosis is associated with a low degree of cortical pathology, only longitudinal studies could definitely confirm this association.
We followed 95 early relapsing-remitting MS (RRMS; median Expanded Disability Status Scale (EDSS) = 1.5, mean disease duration = 3.1 ± 1.3 years) and 45 benign MS patients (EDSS ≤ 3.0, disease duration ≥ 15 years, normal cognition) for 6 years, with EDSS evaluations every 6 months and brain magnetic resonance imaging (MRI) at baseline and then yearly.
At baseline, we detected 406 cortical lesions (CLs) in 67/95 (70.5%) early RRMS and in 24/45 (53.3%) benign MS patients (p = 0.046). After 6 years, the appearance of new CLs was observed in 80/95 (84.2%; 518 CLs) of our early RRMS and in 25/45 (55.5%; 63 CLs; p < 0.001) benign MS patients. At baseline, after corrections for age and disease duration, we observed a cortical thinning of several frontal and temporal regions in our RRMS study patients, compared to the benign MS patients (p ranging between 0.001-0.05). After 6 years, the cortical thinning had increased significantly in several cortices of RRMS patients, but only in the occipital-temporal (p = 0.036) and superior parietal gyrus (p = 0.035) of those with benign MS. Stepwise regression analysis revealed the CL volume (p = 0.006) and the cortical thickness of the temporal middle (p < 0.001), insular long (p < 0.001), superior frontal (p < 0.001) and middle frontal gyri (p < 0.001) as the most sensitive independent predictors of a favorable disease course.
Our data confirmed that a significantly milder cortical pathology characterizes the most favorable clinical course of MS. Measures of focal and diffuse grey matter should be combined to increase the accuracy in the identification of a benign MS course.
尽管多发性硬化症(MS)的病程更有利与皮质病变程度较低有关,但只有纵向研究才能明确证实这种关联。
我们对 95 例早期复发缓解型 MS(RRMS;扩展残疾状态量表(EDSS)中位数= 1.5,平均病程= 3.1±1.3 年)和 45 例良性 MS 患者(EDSS≤3.0,病程≥15 年,认知正常)进行了 6 年的随访,每 6 个月进行一次 EDSS 评估,基线和每年进行一次脑部磁共振成像(MRI)检查。
基线时,我们在 67/95(70.5%)例早期 RRMS 和 24/45(53.3%)例良性 MS 患者中发现了 406 个皮质病变(CL)(p=0.046)。6 年后,我们在 80/95(84.2%;518 个 CL)例早期 RRMS 和 25/45(55.5%;63 个 CL)例良性 MS 患者中观察到新的 CL 出现(p<0.001)。基线时,在对年龄和病程进行校正后,我们发现 RRMS 研究患者的几个额颞区皮质变薄,与良性 MS 患者相比(p 介于 0.001-0.05)。6 年后,RRMS 患者的几个皮质变薄明显增加,但只有良性 MS 患者的枕颞部(p=0.036)和顶上回(p=0.035)。逐步回归分析显示 CL 体积(p=0.006)和颞中回皮质厚度(p<0.001)、岛叶长回皮质厚度(p<0.001)、额上回皮质厚度(p<0.001)和额中回皮质厚度(p<0.001)是疾病预后良好的最敏感独立预测因子。
我们的数据证实,皮质病变明显较轻是 MS 最有利临床病程的特征。应结合局灶性和弥漫性灰质测量来提高识别良性 MS 病程的准确性。